Thyroid Hormone Abuse in Elite Sports: The Regulatory Challenge

J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3562-e3573. doi: 10.1210/clinem/dgac223.

Abstract

Abuse of androgens and erythropoietin has led to hormones being the most effective and frequent class of ergogenic substances prohibited in elite sports by the World Anti-Doping Agency (WADA). At present, thyroid hormone (TH) abuse is not prohibited, but its prevalence among elite athletes and nonprohibited status remains controversial. A corollary of prohibiting hormones for elite sports is that endocrinologists must be aware of a professional athlete's risk of disqualification for using prohibited hormones and/or to certify Therapeutic Use Exemptions, which allow individual athletes to use prohibited substances for valid medical indications. This narrative review considers the status of TH within the framework of the WADA Code criteria for prohibiting substances, which requires meeting 2 of 3 equally important criteria of potential performance enhancement, harmfulness to health, and violation of the spirit of sport. In considering the valid clinical uses of TH, the prevalence of TH use among young adults, the reason why some athletes seek to use TH, and the pathophysiology of sought-after and adverse effects of TH abuse, together with the challenges of detecting TH abuse, it can be concluded that, on the basis of present data, prohibition of TH in elite sport is neither justified nor feasible.

Keywords: sports; thyroid hormone.

Publication types

  • Review

MeSH terms

  • Athletes
  • Doping in Sports*
  • Hormones
  • Humans
  • Performance-Enhancing Substances*
  • Sports*
  • Thyroid Hormones
  • Young Adult

Substances

  • Hormones
  • Performance-Enhancing Substances
  • Thyroid Hormones